BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 9457747)

  • 21. [Molecular genetics of Alport syndrome].
    Yamazaki H; Saito A; Nakagawa Y; Arakawa M
    Nihon Rinsho; 1992 Dec; 50(12):3021-6. PubMed ID: 1491454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical and molecular genetic evidence for type IV collagen alpha5 chain abnormality in the anterior lenticonus associated with Alport syndrome.
    Ohkubo S; Takeda H; Higashide T; Ito M; Sakurai M; Shirao Y; Yanagida T; Oda Y; Sado Y
    Arch Ophthalmol; 2003 Jun; 121(6):846-50. PubMed ID: 12796257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal basement membrane abnormalities and the retinopathy of Alport syndrome.
    Savige J; Liu J; DeBuc DC; Handa JT; Hageman GS; Wang YY; Parkin JD; Vote B; Fassett R; Sarks S; Colville D
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1621-7. PubMed ID: 19850830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome.
    Cheong HI; Kashtan CE; Kim Y; Kleppel MM; Michael AF
    Lab Invest; 1994 Apr; 70(4):553-7. PubMed ID: 8176894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clear lens phacoemulsification in the anterior lenticonus due to Alport Syndrome: two case reports.
    Aslanzadeh GA; Gharabaghi D; Naderi N
    J Med Case Rep; 2008 May; 2():178. PubMed ID: 18505549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corneal clouding in Alport syndrome.
    Herwig MC; Eter N; Holz FG; Loeffler KU
    Cornea; 2011 Mar; 30(3):367-70. PubMed ID: 21045658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The retinal "lozenge" or "dull macular reflex" in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure.
    Colville D; Wang YY; Tan R; Savige J
    Br J Ophthalmol; 2009 Mar; 93(3):383-6. PubMed ID: 19019929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome.
    Shaw EA; Colville D; Wang YY; Zhang KW; Dagher H; Fassett R; Guymer R; Savige J
    Nephrol Dial Transplant; 2007 Jan; 22(1):104-8. PubMed ID: 17071739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maculopathy, Fundus Changes and Anterior Lenticonus in Alport Syndrome.
    Ratkovic M; Pidro A; Pidro A
    Beyoglu Eye J; 2021; 6(1):66-69. PubMed ID: 35005495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
    Chen N; Pan X; Ren H; Dong D
    Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular manifestations and surgical results in patients with Alport syndrome.
    Seymenoğlu G; Baser EF
    J Cataract Refract Surg; 2009 Jul; 35(7):1302-6. PubMed ID: 19545823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
    Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral anterior lenticonus: Scheimpflug imaging system documentation and ultrastructural confirmation of Alport syndrome in the lens capsule.
    Junk AK; Stefani FH; Ludwig K
    Arch Ophthalmol; 2000 Jul; 118(7):895-7. PubMed ID: 10900100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anterior lens capsule abnormalities in Alport syndrome.
    Choi Jh; Na Ks; Bae Sh; Roh Gh
    Korean J Ophthalmol; 2005 Mar; 19(1):84-9. PubMed ID: 15929494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dot-and-fleck retinopathy in Alport syndrome caused by a novel mutation in the COL4A5 gene.
    Blasi MA; Rinaldi R; Renieri A; Petrucci R; De Bernardo C; Bruttini M; Grammatico P
    Am J Ophthalmol; 2000 Jul; 130(1):130-1. PubMed ID: 11004279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of alpha5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome.
    Nakanishi K; Iijima K; Kuroda N; Inoue Y; Sado Y; Nakamura H; Yoshikawa N
    J Am Soc Nephrol; 1998 Aug; 9(8):1433-40. PubMed ID: 9697665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alport syndrome with bilateral simultaneous anterior and posterior lenticonus with severe temporal macular thinning.
    Gupta V; Jamil M; Luthra S; Puthalath AS
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31420426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alport retinopathy results from "severe" COL4A5 mutations and predicts early renal failure.
    Tan R; Colville D; Wang YY; Rigby L; Savige J
    Clin J Am Soc Nephrol; 2010 Jan; 5(1):34-8. PubMed ID: 19965530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ophthalmologic assessment of young patients with Alport syndrome.
    Jacobs M; Jeffrey B; Kriss A; Taylor D; Sa G; Barratt TM
    Ophthalmology; 1992 Jul; 99(7):1039-44. PubMed ID: 1495781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.